Literature DB >> 16797287

Sirolimus-induced intractable chronic diarrhea: a case report.

A A Alkhatib1.   

Abstract

Sirolimus is a macrolide that is extensively used in transplant clinics. The most common side effects of sirolimus are hypertriglyceridemia, hypercholesterolemia, hypertension, rash, and well-tolerated diarrhea. Herein I have reported a case of intractable, disabling, chronic diarrhea secondary to sirolimus in a renal transplant recipient. The sirolimus dose had been recently increased from 2 mg to 5 mg 1 month before the patient began to complain of severe diarrhea. In addition to the case presentation, the literature is reviewed as well as possible mechanisms of sirolimus-induced diarrhea are discussed. In conclusion, clinicians should consider sirolimus as a potential etiology for severe chronic diarrhea among patients who are treated with sirolimus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797287     DOI: 10.1016/j.transproceed.2006.02.123

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Rapamycin Inhibition of mTOR Reduces Levels of the Na+/H+ Exchanger 3 in Intestines of Mice and Humans, Leading to Diarrhea.

Authors:  Jun Yang; Xiaofeng Zhao; Archana Patel; Rachana Potru; Sadra Azizi-Ghannad; Michael Dolinger; James Cao; Catherine Bartholomew; Joseph Mazurkiewicz; David Conti; David Jones; Yunfei Huang; Xinjun Cindy Zhu
Journal:  Gastroenterology       Date:  2015-03-30       Impact factor: 22.682

2.  Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

Authors:  Rosalba Siracusa; Irene Paterniti; Marika Cordaro; Rosalia Crupi; Giuseppe Bruschetta; Michela Campolo; Salvatore Cuzzocrea; Emanuela Esposito
Journal:  Mol Neurobiol       Date:  2017-03-29       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.